Barclays
TRAW icon

Barclays’s Traws Pharma TRAW Stock Holding History

Barclays’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64K Buy
+1,947
New +$2.68K ﹤0.01% 4892
2021
Q2 		– Sell
-173
Closed -$65K – 5113
2021
Q1 		$65K Buy
173
+170
+5,667% +$64.1K ﹤0.01% 4144
2020
Q4 		$0 Hold
3
– – ﹤0.01% 5190
2020
Q3 		$0 Sell
3
-264
-99% -$65.3K ﹤0.01% 5648
2020
Q2 		$57K Buy
+267
New +$40.8K ﹤0.01% 4868
2020
Q1 		– Hold
0
– – – 6519
2019
Q4 		– Hold
0
– – – 6881
2019
Q3 		– Hold
0
– – – 7192
2018
Q2 		– Hold
0
– – – 7342
2018
Q1 		– Hold
0
– – – 7381
2015
Q2 		– Hold
0
– – – 7238
2015
Q1 		– Hold
0
– – – 7296
2014
Q4 		– Hold
0
– – – 7130
2014
Q3 		– Hold
0
– – – 7129
2014
Q2 		– Hold
0
– – – 6379
2014
Q1 		– Hold
0
– – – 6538
2013
Q4 		– Hold
0
– – – 7457
2013
Q3 		– Hold
0
– – – 6829

Other funds holding TRAW

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Barclays's TRAW Position: Q2 2026 in Review

Barclays opened a new position in Traws Pharma (TRAW) in Q2 2026: 1,947 shares worth $1.64K. The stake represents ﹤0.01% of the portfolio and ranks #4892 among its holdings. This is a return to the name: Barclays previously reported a position in TRAW as recently as Q1 2021.

Barclays first reported a position in TRAW in Q2 2020 and has held it in 5 quarters since. The position peaked at $65K in Q1 2021. 35 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.

  • Barclays held 1,947 shares of Traws Pharma worth $1.64K as of Q2 2026.
  • Traws Pharma was a new Barclays position in Q2 2026.
  • Traws Pharma made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4892 holding.
  • Barclays first reported a position in Traws Pharma in Q2 2020 and has held it in 5 quarters since.
  • Barclays's Traws Pharma position peaked at $65K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.